Stocksigma LogoStocksigma Logo

Alivus Life Sciences Board to Consider Q2FY27 Results on 29th Oct'26

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve

Alivus Life Sciences Board to Consider Q2FY27 Results on 29th Oct'26

Alivus Life Sciences Ltd 路 Intimation 路 29 Oct 2026, 5:30 am

Alivus Life Sciences Board to Consider Q2FY27 Results on 29th Oct'26 Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has scheduled a Board of Directors meeting on 29th Oct'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company's trading window for designated persons remains closed from 1st Oct'26 to 31st Oct'26 (both days inclusive) in compliance with SEBI insider trading regulations.

Original exchange filing (PDF)

More announcements from Alivus Life Sciences Ltd

All Alivus Life Sciences Ltd announcements